Incidence and clinical importance of bone marrow eosinophilia in Hodgkin's disease (BNLI Report No 29). British National Lymphoma Investigation.

Podobne zapisy

• Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.
  od: Vaughan Hudson, B, i wsp.
  Wydane: (1987)
• Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.
  od: Devereux, S, i wsp.
  Wydane: (1990)
• Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
  od: Vaughan Hudson, B., i wsp.
  Wydane: (1994)
• Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases.
  od: Morton, J. E., i wsp.
  Wydane: (1993)
• Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI)
  od: Yung, L, i wsp.
  Wydane: (2004)